4 measures of EHR, clinical documentation effectiveness

Electronic health records (EHRs) have become an integral part of the healthcare system, but how do clinicians view this technology?  In a study conducted by Nuance, researchers analyze multiple factors in how clinicians view and use EHRs in everyday care.

The study used an online survey to ask a variety of questions to C-Suite, IT leadership and additional clinicians to gauge their views on EHRs in healthcare. The study included the following:

When asked how confident they were in their organizations to realize the benefits on EHR:

  • Overall, 83 percent reported confidence in EHRs.
  • 46.7 percent were somewhat confident.
  • 35.9 percent reported being very confident.

When asked how their administrative staff or resources have changed in response to EHRs:

  • 77 percent reported changes in training and support.
  • 63 percent reported changes in software development.
  • 61 percent reported changes in staff involved with information governance.

When asked what the organizations is doing to improve clinicians' satisfaction with EHRs:

  • 82 percent reported improvements in education of staff.
  • 75 percent reported improvements in existing technologies.
  • 67 percent reported improvements in adopting new technologies.

When asked how to further improve the financial impact of EHRs:

  • 67 percent reported the ability to capture reimbursements.
  • 54 percent reported reductions in denied claims.
  • 52 percent reported improved performance under Bundled payments.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.